9.30
price up icon2.54%   0.23
after-market After Hours: 9.23 -0.07 -0.75%
loading
Emergent Biosolutions Inc stock is traded at $9.30, with a volume of 595.28K. It is up +2.54% in the last 24 hours and up +14.25% over the past month. Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
See More
Previous Close:
$9.07
Open:
$9.15
24h Volume:
595.28K
Relative Volume:
0.54
Market Cap:
$496.17M
Revenue:
$1.02B
Net Income/Loss:
$-757.20M
P/E Ratio:
-0.6301
EPS:
-14.76
Net Cash Flow:
$-257.90M
1W Performance:
+1.75%
1M Performance:
+14.25%
6M Performance:
+111.85%
1Y Performance:
+6.29%
1-Day Range:
Value
$9.13
$9.405
1-Week Range:
Value
$9.06
$10.10
52-Week Range:
Value
$4.02
$12.73

Emergent Biosolutions Inc Stock (EBS) Company Profile

Name
Name
Emergent Biosolutions Inc
Name
Phone
240-631-3200
Name
Address
300 PROFESSIONAL DR, GAITHERSBURG, MD
Name
Employee
900
Name
Next Earnings Date
2025-03-03
Name
Latest SEC Filings
Name
EBS's Discussions on Twitter

Compare EBS with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
EBS
Emergent Biosolutions Inc
9.30 483.89M 1.02B -757.20M -257.90M -14.76
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
142.26 62.54B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.72 43.30B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.08 40.08B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.02 22.98B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
440.06 19.90B 3.08B 1.24B 1.07B 25.61

Emergent Biosolutions Inc Stock (EBS) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-30-24 Initiated H.C. Wainwright Buy
Aug-22-24 Initiated Rodman & Renshaw Buy
Mar-07-24 Upgrade The Benchmark Company Hold → Buy
Nov-20-23 Resumed JP Morgan Underweight
Aug-29-23 Downgrade The Benchmark Company Buy → Hold
Apr-10-23 Upgrade The Benchmark Company Hold → Buy
Mar-17-23 Downgrade JP Morgan Neutral → Underweight
Nov-10-22 Downgrade The Benchmark Company Buy → Hold
Apr-29-22 Downgrade Cantor Fitzgerald Overweight → Neutral
Jan-20-22 Upgrade The Benchmark Company Hold → Buy
Nov-08-21 Downgrade The Benchmark Company Buy → Hold
May-05-21 Downgrade Argus Buy → Hold
Apr-07-21 Initiated The Benchmark Company Buy
Feb-24-21 Upgrade Chardan Capital Markets Neutral → Buy
Feb-19-21 Downgrade Chardan Capital Markets Buy → Neutral
Jan-08-21 Downgrade Wells Fargo Overweight → Equal Weight
Sep-14-20 Resumed JP Morgan Neutral
Jul-31-20 Reiterated Chardan Capital Markets Buy
Sep-12-19 Initiated Guggenheim Buy
Sep-04-19 Upgrade Wells Fargo Market Perform → Outperform
Nov-02-18 Upgrade Goldman Neutral → Buy
Aug-03-18 Reiterated Chardan Capital Markets Buy
Jun-13-18 Initiated Argus Buy
Apr-25-18 Downgrade Wells Fargo Outperform → Market Perform
Jan-24-18 Initiated Goldman Neutral
Jan-16-18 Reiterated Chardan Capital Markets Buy
Jun-28-16 Reiterated Singular Research Buy
Apr-15-16 Initiated Chardan Capital Markets Buy
Mar-28-16 Initiated Singular Research Buy
Feb-19-16 Initiated Wells Fargo Outperform
May-15-14 Initiated Summer Street Research Buy
May-31-11 Reiterated WBB Securities Strong Buy
Jan-10-11 Reiterated Wedbush Outperform
Nov-05-10 Reiterated Wedbush Outperform
Aug-18-10 Upgrade WBB Securities Buy → Strong Buy
Aug-06-10 Reiterated Caris & Company Buy
View All

Emergent Biosolutions Inc Stock (EBS) Latest News

pulisher
12:00 PM

Why Emergent BioSolutions Inc. stock remains resilientShare Buyback & Daily Profit Focused Screening - newser.com

12:00 PM
pulisher
11:52 AM

Is Emergent BioSolutions Inc. stock dividend yield sustainableMarket Performance Report & Free Accurate Trade Setup Notifications - newser.com

11:52 AM
pulisher
11:29 AM

What earnings revisions data tells us about Emergent BioSolutions Inc.2025 Price Action Summary & Free Technical Pattern Based Buy Signals - newser.com

11:29 AM
pulisher
09:10 AM

Will Emergent BioSolutions Inc. stock return to pre crisis levelsJuly 2025 Analyst Calls & AI Powered Buy and Sell Recommendations - newser.com

09:10 AM
pulisher
08:51 AM

Pattern recognition hints at Emergent BioSolutions Inc. upsideJuly 2025 Summary & Real-Time Stock Price Movement Reports - newser.com

08:51 AM
pulisher
03:46 AM

Reversal indicators forming on Emergent BioSolutions Inc. stockJuly 2025 Catalysts & Smart Allocation Stock Reports - newser.com

03:46 AM
pulisher
Oct 10, 2025

Short interest data insights for Emergent BioSolutions Inc.July 2025 Spike Watch & Expert Approved Momentum Trade Ideas - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

How strong is Emergent BioSolutions Inc. stock balance sheetJuly 2025 Update & Consistent Profit Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Emergent Biosolutions (NYSE:EBS) Given "Sell (D)" Rating at Weiss Ratings - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Is Emergent BioSolutions Inc. (ER4) stock dividend growth reliableQuarterly Trade Summary & Real-Time Sentiment Analysis - newser.com

Oct 10, 2025
pulisher
Oct 08, 2025

Emergent BioSolutions Inc.'s (NYSE:EBS) Shares Bounce 31% But Its Business Still Trails The Industry - simplywall.st

Oct 08, 2025
pulisher
Oct 08, 2025

Emergent BioSolutions to Report Third Quarter 2025 Financial Results on October 29, 2025 - The Manila Times

Oct 08, 2025
pulisher
Oct 08, 2025

Emergent BioSolutions Inc. Announces Conference Call for Third Quarter 2025 Financial Results - Quiver Quantitative

Oct 08, 2025
pulisher
Oct 08, 2025

Oct 29: Emergent BioSolutions to Report Q3 Results; Webcast and Call Registration Details - Stock Titan

Oct 08, 2025
pulisher
Oct 07, 2025

Emergent Biosolutions (NYSE:EBS) Stock Price Up 5.3%Still a Buy? - MarketBeat

Oct 07, 2025
pulisher
Oct 07, 2025

Emergent Biosolutions (NYSE:EBS) Share Price Crosses Above 200 Day Moving AverageShould You Sell? - MarketBeat

Oct 07, 2025
pulisher
Oct 06, 2025

Quantitative breakdown of Emergent BioSolutions Inc. recent moveTrade Ideas & Growth Focused Entry Reports - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Why Emergent BioSolutions Inc. (ER4) stock is listed among top recommendationsWeekly Market Summary & Free Safe Entry Trade Signal Reports - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Is Emergent BioSolutions Inc. (ER4) stock a buy during volatile marketsJuly 2025 Opening Moves & Short-Term High Return Ideas - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Published on: 2025-10-05 04:23:16 - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Is Emergent BioSolutions Inc. stock a top pick in earnings season2025 Market Sentiment & Fast Moving Trade Plans - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Relative strength of Emergent BioSolutions Inc. in sector analysisWeekly Trend Summary & Long-Term Capital Growth Ideas - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

How to interpret RSI for Emergent BioSolutions Inc. stockPortfolio Update Report & Weekly Setup with ROI Potential - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Strategies to average down on Emergent BioSolutions Inc.Portfolio Value Report & AI Powered Market Trend Analysis - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Multi factor analysis applied to Emergent BioSolutions Inc.CEO Change & Entry Point Strategy Guides - newser.com

Oct 03, 2025
pulisher
Sep 28, 2025

Is Emergent BioSolutions Inc. stock poised for growth2025 Stock Rankings & Consistent Profit Alerts - newser.com

Sep 28, 2025
pulisher
Sep 28, 2025

Emergent BioSolutions Inc Stock Analysis and ForecastVolatility Index Analysis & Big Profit Small Budget - earlytimes.in

Sep 28, 2025
pulisher
Sep 27, 2025

Is Emergent BioSolutions Inc ER4 a good long term investmentMarket Insider Reports & Affordable Investment Strategies - Early Times

Sep 27, 2025

Emergent Biosolutions Inc Stock (EBS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Emergent Biosolutions Inc Stock (EBS) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Zoon Kathryn C
Director
Aug 15 '25
Sale
8.87
7,086
62,853
71,799
$20.04
price up icon 1.42%
$9.86
price up icon 1.23%
$54.73
price up icon 1.45%
drug_manufacturers_specialty_generic RDY
$14.36
price up icon 0.14%
$137.35
price up icon 0.53%
$440.06
price up icon 0.01%
Cap:     |  Volume (24h):